Related Experiment Video
Updated: Aug 17, 2026

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
Published on: December 29, 2012
Autoreactive cells as mediators of the natural defense against malignant tumors
Abstract:
The present paper suggests that the natural defense mechanisms against tumors are part and a logical consequence of the natural mechanisms that maintain tissue uniformity. We further suggest that biologic errors steadily are accumulated in cells with increasing age, and that the number of cells with insufficient functional capacity (aberrant cells) increases with age. Since this increasing number of aberrant cells threatens the uniformity and function of the cell population, aberrant cells must be removed in order to maintain tissue uniformity. The aberrant cells may be removed by autonomous destruction or by cytotoxic attack by autoreactive cells. Such autoreactive cells are present in the normal organism throughout life, may be suppressed by thymus-derived cells, and may be activated by immune adjuvants. We suggest from theoretic and experimental reasons that the major function of autoreactive cells is the maintenance of tissue uniformity and tissue homeostasis within a cell population.
Related Concept Videos
Cell-mediated Immune Responses
The Tumor Microenvironment
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy

